Cheops Technology France Société anonyme (EPA:MLCHE)

Elevation Oncology Ratios and Metrics

Market cap in millions EUR. Fiscal year is May - April.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 28, 2025	Apr 30, 2024	Apr 30, 2023	Apr 30, 2022	Apr 30, 2021	Apr 30, 2020
Market Capitalization	145	141	150	179	102	76
Market Cap Growth	86.36%	-5.38%	-16.67%	75.68%	34.54%	-23.26%
Enterprise Value	130	129	137	159	84	58
Last Close Price	63.00	61.50	63.54	74.25	38.81	28.30
PE Ratio	20.26	19.77	22.00	30.53	17.80	16.11
PS Ratio	0.90	0.88	1.01	1.40	0.86	0.68
PB Ratio	5.15	5.03	6.13	8.55	3.40	2.92
P/TBV Ratio	7.45	7.28	9.70	15.31	5.00	4.27
EV/Sales Ratio	0.81	0.81	0.93	1.24	0.71	0.51
EV/EBITDA Ratio	12.75	12.67	13.60	17.81	9.18	8.31
EV/EBIT Ratio	14.70	14.62	15.48	20.39	10.20	9.35
Debt / Equity Ratio	0.41	0.41	0.13	0.22	0.23	0.10
Debt / EBITDA Ratio	1.12	1.12	0.32	0.52	0.77	0.38
Asset Turnover	1.99	1.99	1.99	1.71	1.63	1.69
Inventory Turnover	2099.25	2099.25	1676.02	1333.40	1065.04	793.16
Quick Ratio	1.31	1.31	1.24	1.04	1.38	1.29
Current Ratio	1.38	1.38	1.32	1.11	1.44	1.34
Return on Equity (ROE)	27.25%	27.25%	29.96%	23.04%	20.50%	18.61%
Return on Assets (ROA)	6.83%	6.83%	7.44%	6.51%	7.05%	5.81%
Return on Capital (ROIC)	16.46%	16.46%	20.82%	15.59%	15.64%	13.44%
Return on Capital Employed (ROCE)	23.00%	23.00%	27.00%	31.70%	21.90%	21.00%
Earnings Yield	4.94%	5.06%	4.54%	3.28%	5.62%	6.21%
Dividend Yield	-	-	-	6.73%	3.81%	-
Total Shareholder Return	-	-	-	6.73%	3.81%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.